Claritev Corporation (CTEV) Stock

Claritev Corporation (CTEV) is a Technology stock trading at $29.10 (as of 2026-06-18), with a market capitalization of $428.24M and a trailing P/E of -1.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Claritev Corporation provides healthcare-focused data analytics and technology-enabled services for cost management, including identifying and addressing improper or unnecessary charges in medical claims and supporting payment and revenue integrity. It also offers analytics and decision science solutions and provider network-related services, serving customers in the United States.

Valuation — source: SEC EDGAR (first-party)
Price	$29.10
Market Cap	$428.24M
P/E Ratio	-1.8
EV / EBITDA	40.1
Price / Book	-2.25
Price / Sales	0.54
DCF Value (model)	$-290.44
DCF Upside vs Price	-1098.1%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$965.41M
Net Margin	-29.4%
Return on Equity	122.2%
Debt / Equity	-19.79
Current Ratio	1.28
Revenue Growth (YoY)	5.8%
EPS Growth (YoY)	0.7%
FCF Growth (YoY)	34.3%

Financial Health — source: SEC EDGAR
Altman Z-Score	-0.43 (distress)

Valuation vs Sector & Industry
Stock P/E	-1.8
Sector P/E (Technology)	32.6
Industry P/E (Business Services)	27.1
vs Sector	-105.5%
vs Industry	-106.6%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	H&F Corporate Investors VIII, Ltd. ($63.53M)
Institutional Holders Tracked	10

Company
Sector	Technology
Industry	Business Services
CEO	Travis S. Dalton
Employees	2,700
Country	US
IPO Date	2020-04-03

Related Companies (Business model: IT Services / Consulting and Managed Services; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.